Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRSW107 Expansion in Hemophilia A
NCT04845399Phase 3Completed
- Sponsor
- Zhengzhou Gensciences Biotechnology Co Ltd
- Start
- Apr 2021
- Primary completion
- Jun 2021
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human coagulation factor viii-fc fusion protein in hemophilia A, sponsored by Zhengzhou Gensciences Biotechnology Co Ltd. Started Apr 2021; status: completed.
02
Drugs
recombinant human coagulation factor viii-fc fusion protein
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT04845399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04845399.